Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department Patients



Status:Recruiting
Conditions:Cardiology, Infectious Disease, Hospital, Hospital
Therapuetic Areas:Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Other
Healthy:No
Age Range:18 - Any
Updated:2/17/2019
Start Date:November 10, 2018
End Date:October 31, 2020
Contact:Nathan I Shapiro, MD, MPH
Email:nshapiro@bidmc.harvard.edu
Phone:617-754-2343

Use our guide to learn which trials are right for you!

The overall goal of this multicenter project is to characterize the expected normal range of
Peripheral IntraVenous Volume Analysis (PIVA) values during a euvolemic state, and how those
ranges may be altered by comorbidities; the relationship between PIVA and intravenous volume
administration during resuscitation of infected patients with presumed hypovolemia; and, the
relationship between PIVA and volume decreases during diuresis in acute heart failure
patients with hypervolemia.

The determination of volume status remains a clinical challenge in medicine. Patients may
develop hypovolemia (too little fluids in the vascular space) due to conditions such as
hemorrhage, dehydration, or infection with vascular leak. Alternatively, patients may become
hypervolemic (too much fluids in the vascular space), due to conditions such as heart
failure, renal failure, or iatragenic over-resuscitation all of which overwhelm the kidney's
ability to regulate intravascular volume status. In clinical practice, clinicians strive to
return patients to euvolemia (the "right" volume status) through the administration of
intravenous fluids or diuretics which remove fluids to achieve homeostasis. While there are a
number of proposed clinical exam findings (e.g. dry mucous membranes or skin turgor),
measurements (e.g. central venous pressure), or laboratory tests (e.g. blood urea nitrogen),
none are precise or universally accepted as reliable methodologies to assess volume status.

The goal of this study is to perform a prospective observational study on three distinct
cohorts during ED presentation to assess the variability and performance of PIVA in tracking
volume status.

Control Cohort (Presumed Euvolemia)

Inclusion Criteria:

- Age > 18 years old

- Assessed as "euvolemic" by treating physician

Exclusion Criteria:

- History of any type of decreased oral intake or volume loss (e.g. diarrhea, vomiting,
etc)

- History of a fever

- History of bleeding

- Any acute illness expected to alter volume

- Known or suspected pregnancy

- Active irregular heart rhythm

- In the opinion of the treating physician, no anticipated intravenous fluid
administration

- History of chronic or end stage renal disease

- Liver failure

- History of Acute heart failure

- Presence of abnormal vital signs (90 < HR < 60; 180 < SBP < 110, respiratory rate >
20, pulse ox < 92% or need for supplemental oxygen, 99.0 < temperature < 96).

2 additional group will be included in this euvolemic group

- Non-elderly patients (age < 50 year) without any comorbid illnesses and

- Age >65

- Diabetes on medications

- Hypertension on medications

- Vascular disease defined by history of peripheral vascular disease, stroke, MI

Note: patients that receive >250 cc of IVF will be excluded from analysis.

Infection Cohort (Presumed Hypovolemia)

Inclusion Criteria:

- Age > 18 years old

- An accessible intravenous catheter is in place

- Known or suspected infection as assessed by the clinical team

- Intention to admit to the hospital

- Anticipated administration of intravenous fluids per clinical team

Exclusion Criteria:

- Clinical exam consistent with volume overload

- Known or suspected pregnancy

- Patients with a history of chronic renal insufficiency or end-stage renal disease

- Patients with a history of acute heart failure

Acute Heart Failure (Hypervolemic cohort)

Inclusion Criteria:

- Age > 17 years old

- An accessible intravenous catheter is in place

- Primary clinical diagnosis of CHF

- Meet 2 of the three criterion:

- X-ray diagnosis

- Elevated bnp from known baseline

- Clinical diagnosis

- Received or intent to administer a diuretic agent

- Intent to admit to the hospital for anticipated > 24 hour period

Exclusion Criteria:

- History of any type of decreased oral intake or volume loss (e.g. diarrhea, vomiting,
etc)

- History of a fever

- History of bleeding

- Known or suspected pregnancy

- Active irregular heart rhythm

- History of dialysis dependent end stage renal disease
We found this trial at
3
sites
Seattle, Washington 98104
(206) 543-2100
Univ of Washington Founded in 1861 by a private gift of 10 acres in what...
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Boston, Massachusetts 02215
Principal Investigator: Nathan I Shapiro, MD MPH
Phone: 617-754-2343
?
mi
from
Boston, MA
Click here to add this to my saved trials
Worcester, Massachusetts 01608
Principal Investigator: Nathan Shapiro, MD
Phone: 508-363-5286
?
mi
from
Worcester, MA
Click here to add this to my saved trials